Literature DB >> 24135828

Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders.

N Argentou1, G Vassilopoulos2, M Ioannou3, A E Germenis1, M Speletas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24135828     DOI： 10.1038/leu.2013.294

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  MYD88 L265P somatic mutation in IgM MGUS.

Authors:  Ola Landgren; Louis Staudt
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

2.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Authors:  Steven P Treon; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Patricia Sheehy; Robert J Manning; Christopher J Patterson; Christina Tripsas; Luca Arcaini; Geraldine S Pinkus; Scott J Rodig; Aliyah R Sohani; Nancy Lee Harris; Jason M Laramie; Donald A Skifter; Stephen E Lincoln; Zachary R Hunter
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

Review 3.  Diagnostic criteria for monoclonal B-cell lymphocytosis.

Authors:  Gerald E Marti; Andy C Rawstron; Paolo Ghia; Peter Hillmen; Richard S Houlston; Neil Kay; Thérèse A Schleinitz; Neil Caporaso
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

4.  Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads.

Authors:  T P Leren; O K Rødningen; O Røsby; K Solberg; K Berg
Journal:  Biotechniques       Date:  1993-04       Impact factor: 1.993

5.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

6.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

7.  Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Ellen D Remstein; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

8.  Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.

Authors:  Marzia Varettoni; Luca Arcaini; Silvia Zibellini; Emanuela Boveri; Sara Rattotti; Roberta Riboni; Alessandro Corso; Ester Orlandi; Maurizio Bonfichi; Manuel Gotti; Cristiana Pascutto; Silvia Mangiacavalli; Giorgio Croci; Valeria Fiaccadori; Lucia Morello; Maria Luisa Guerrera; Marco Paulli; Mario Cazzola
Journal:  Blood       Date:  2013-01-25       Impact factor: 22.113

9.  Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2008-08-13       Impact factor: 22.113

10.  Peak height pattern in dichloro-rhodamine and energy transfer dye terminator sequencing.

Authors:  H Zakeri; G Amparo; S M Chen; S Spurgeon; P Y Kwok
Journal:  Biotechniques       Date:  1998-09       Impact factor: 1.993
View more
  7 in total

1.  Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Authors:  L Xu; Z R Hunter; G Yang; Y Cao; X Liu; R Manning; C Tripsas; J Chen; C J Patterson; M Kluk; S Kanan; J Castillo; N Lindeman; S P Treon
Journal:  Leukemia       Date:  2014-02-10       Impact factor: 11.528

Review 2.  MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Authors:  Miguel Alcoceba; María García-Álvarez; Alejandro Medina; Rebeca Maldonado; Verónica González-Calle; María Carmen Chillón; María Eugenia Sarasquete; Marcos González; Ramón García-Sanz; Cristina Jiménez
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

3.  MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation.

Authors:  Martina Ferrante; Daniela Furlan; Silvia Zibellini; Michela Borriero; Chiara Candido; Nora Sahnane; Silvia Uccella; Elisa Genuardi; Beatrice Alessandria; Benedetta Bianchi; Barbara Mora; Daniele Grimaldi; Irene Defrancesco; Cristina Jiménez; Federica Cavallo; Dario Ferrero; Irene Dogliotti; Michele Merli; Marzia Varettoni; Simone Ferrero; Daniela Drandi
Journal:  Diagnostics (Basel)       Date:  2021-04-26

4.  TACI expression and signaling in chronic lymphocytic leukemia.

Authors:  Antigoni Mamara; Anastasios E Germenis; Maria Kompoti; Maria Palassopoulou; Eudokia Mandala; Anastasia Banti; Nikolaos Giannakoulas; Matthaios Speletas
Journal:  J Immunol Res       Date:  2015-04-09       Impact factor: 4.818

5.  Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia

Authors:  Yasser B.M Ali; Rasha M Foad; Essam Abdel-Wahed
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

Review 6.  Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.

Authors:  Daniela Drandi; Philippe Decruyenaere; Martina Ferrante; Fritz Offner; Jo Vandesompele; Simone Ferrero
Journal:  Diagnostics (Basel)       Date:  2022-04-12

7.  MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker.

Authors:  Sandhya Narasimhan; Mayur Joshi; Sowmya Parameswaran; Pukhraj Rishi; Vikas Khetan; Suganeswari Ganesan; Jyotirmay Biswas; Natarajan Sundaram; Janani Sreenivasan; Sonali Verma; Vanitha Krishnamurthy; Krishnakumar Subramanian
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.